APA (7th ed.) Citation

A, Y., V, P., R, A., S, L., L, S., D, G., . . . M, H. (2026). VLX-1005, but not argatroban, prevents ITAM-mediated platelet activation and heparin-induced thrombocytopenia. Blood vessels, thrombosis & hemostasis, 3(2), 100146. https://doi.org/10.1016/j.bvth.2026.100146

Chicago Style (17th ed.) Citation

A, Yamaguchi, et al. "VLX-1005, but Not Argatroban, Prevents ITAM-mediated Platelet Activation and Heparin-induced Thrombocytopenia." Blood Vessels, Thrombosis & Hemostasis 3, no. 2 (2026): 100146. https://doi.org/10.1016/j.bvth.2026.100146.

MLA (9th ed.) Citation

A, Yamaguchi, et al. "VLX-1005, but Not Argatroban, Prevents ITAM-mediated Platelet Activation and Heparin-induced Thrombocytopenia." Blood Vessels, Thrombosis & Hemostasis, vol. 3, no. 2, 2026, p. 100146, https://doi.org/10.1016/j.bvth.2026.100146.